Activated immune cells in Parkinson's disease

Journal of Neuroimmune Pharmacology

Volumn 6, Issue 3, 2011, Pages 323-329

  Cao, Jun Jun ^a   Li, Kang Sheng ^a   Shen, Yan Qin ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Cytokines; Microglia; Parkinson's disease; T lymphocytes

Indexed keywords

ADAPTIVE IMMUNITY; CELL ACTIVATION; CELL INTERACTION; DISEASE COURSE; HUMAN; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LYMPHOCYTIC INFILTRATION; MICROGLIA; NERVE CELL PLASTICITY; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; DISEASE PROGRESSION; HUMANS; MICROGLIA; PARKINSON DISEASE; T-LYMPHOCYTE SUBSETS;

EID: 79960610151     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-011-9280-9     Document Type: Review

References (49)

1. SH Appel DR Beers JS Henkel 2010 T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening? Trends Immunol 31 7 17 19879804 10.1016/j.it.2009.09.003 1:CAS:528: DC%2BC3cXkt1ejtQ%3D%3D
2. R Arnon R Aharoni 2004 Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications Proc Natl Acad Sci USA 101 Suppl 2 14593 14598 15371592 10.1073/pnas.0404887101 1:CAS:528:DC%2BD2cXovVeqsrY%3D (Pubitemid 39346729)
3. Y Baba A Kuroiwa RJ Uitti ZK Wszolek T Yamada 2005 Alterations of T-lymphocyte populations in Parkinson disease Parkinsonism Relat Disord 11 493 498 16154792 10.1016/j.parkreldis.2005.07.005 (Pubitemid 41627840)
4. J Bas M Calopa M Mestre DG Mollevi B Cutillas S Ambrosio E Buendia 2001 Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism J Neuroimmunol 113 146 152 11137586 10.1016/S0165-5728(00)00422-7 1:CAS:528:DC%2BD3MXhsVSrt70%3D (Pubitemid 32008680)
5. PE Batchelor GT Liberatore JY Wong MJ Porritt F Frerichs GA Donnan DW Howells 1999 Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor J Neurosci 19 1708 1716 10024357 1:CAS:528:DyaK1MXhtlCrtL8%3D (Pubitemid 29094189)
6. PE Batchelor GT Liberatore MJ Porritt GA Donnan DW Howells 2000 Inhibition of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor expression reduces dopaminergic sprouting in the injured striatum Eur J Neurosci 12 3462 3468 11029615 10.1046/j.1460-9568.2000.00239.x 1:STN:280:DC%2BD3M%2Fjtlegtg%3D%3D
7. EJ Benner RL Mosley CJ Destache TB Lewis V Jackson-Lewis S Gorantla C Nemachek SR Green S Przedborski HE Gendelman 2004 Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease Proc Natl Acad Sci USA 101 9435 9440 15197276 10.1073/pnas.0400569101 1:CAS:528: DC%2BD2cXltlKjsLk%3D (Pubitemid 38812892)
8. EJ Benner R Banerjee AD Reynolds S Sherman VM Pisarev V Tsiperson C Nemachek P Ciborowski S Przedborski RL Mosley HE Gendelman 2008 Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons PLoS ONE 3 e1376 18167537 10.1371/journal.pone.0001376 (Pubitemid 351223140)
9. G Boka P Anglade D Wallach F Javoy-Agid Y Agid EC Hirsch 1994 Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease Neurosci Lett 172 151 154 8084523 10.1016/0304-3940(94) 90684-X 1:CAS:528:DyaK2cXkvVSitro%3D (Pubitemid 24178765)
10. V Brochard B Combadiere A Prigent Y Laouar A Perrin V Beray-Berthat O Bonduelle D Alvarez-Fischer J Callebert JM Launay C Duyckaerts RA Flavell EC Hirsch S Hunot 2009 Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease J Clin Invest 119 182 192 19104149 1:CAS:528:DC%2BD1MXmtFCgsA%3D%3D
11. CC Chao S Hu K Close CS Choi TW Molitor WJ Novick PK Peterson 1992 Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone J Infect Dis 166 847 853 1527422 10.1093/infdis/166.4.847 1:CAS:528:DyaK38XmsVGiu7Y%3D
12. VY Chock RG Giffard 2005 Development of neonatal murine microglia in vitro: changes in response to lipopolysaccharide and ischemia-like injury Pediatr Res 57 475 480 15718374 10.1203/01.PDR.0000155758.79523.44 1:CAS:528:DC%2BD2MXitlOju7c%3D (Pubitemid 40389333)
13. A Czlonkowska M Kohutnicka I Kurkowska-Jastrzebska A Czlonkowski 1996 Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model Neurodegeneration 5 137 143 8819134 10.1006/neur.1996.0020 1:STN:280:DyaK28vhs1ahug%3D%3D (Pubitemid 26248603)
14. LM de Lau MM Breteler 2006 Epidemiology of Parkinson's disease Lancet Neurol 5 525 535 16713924 10.1016/S1474-4422(06)70471-9 (Pubitemid 44262284)
15. AL De Lella Ezcurra M Chertoff C Ferrari M Graciarena F Pitossi 2010 Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation Neurobiol Dis 37 630 640 19969084 10.1016/j.nbd.2009.11.018
16. M Delgado A Chorny E Gonzalez-Rey D Ganea 2005 Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo J Leukoc Biol 78 1327 1338 16204628 10.1189/jlb.0605299 1:CAS:528:DC%2BD2MXhtleksLvP (Pubitemid 41779239)
17. CC Ferrari MC Pott Godoy R Tarelli M Chertoff AM Depino FJ Pitossi 2006 Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra Neurobiol Dis 24 183 193 16901708 10.1016/j.nbd.2006.06.013 1:CAS:528:DC%2BD28XpvFGjurw%3D (Pubitemid 44437611)
18. U Fiszer E Mix S Fredrikson V Kostulas H Link 1994 Parkinson's disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood Acta Neurol Scand 90 160 166 7847055 10.1111/j.1600-0404.1994.tb02699.x 1:STN:280: DyaK2M7kvFKksA%3D%3D (Pubitemid 24305916)
19. DM Gash Z Zhang A Ovadia WA Cass A Yi L Simmerman D Russell D Martin PA Lapchak F Collins BJ Hoffer GA Gerhardt 1996 Functional recovery in parkinsonian monkeys treated with GDNF Nature 380 252 255 8637574 10.1038/380252a0 1:CAS:528:DyaK28XhvVahsL8%3D (Pubitemid 26090648)
20. A Gerhard N Pavese G Hotton F Turkheimer M Es A Hammers K Eggert W Oertel RB Banati DJ Brooks 2006 In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease Neurobiol Dis 21 404 412 16182554 10.1016/j.nbd.2005.08.002 1:CAS:528:DC%2BD28XmsVGmsg%3D%3D (Pubitemid 43099863)
21. A Ghosh A Roy X Liu JH Kordower EJ Mufson DM Hartley S Ghosh RL Mosley HE Gendelman K Pahan 2007 Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease Proc Natl Acad Sci USA 104 18754 18759 18000063 10.1073/pnas.0704908104 1:CAS:528:DC%2BD2sXhtl2lt7vP (Pubitemid 350210769)
22. E Gonzalez-Rey A Chorny A Fernandez-Martin D Ganea M Delgado 2006 Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells Blood 107 3632 3638 16397128 10.1182/blood-2005-11-4497 1:CAS:528:DC%2BD28Xkt1Giur0%3D
23. WG Kim RP Mohney B Wilson GH Jeohn B Liu JS Hong 2000 Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia J Neurosci 20 6309 6316 10934283 1:CAS:528: DC%2BD3cXlvVGjtbs%3D (Pubitemid 30658427)
24. S Kim M Moon S Park 2009 Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease J Endocrinol 202 431 439 19570816 10.1677/JOE-09-0132 1:CAS:528:DC%2BD1MXhtFahtLnF
25. M Kohutnicka E Lewandowska I Kurkowska-Jastrzebska A Czlonkowski A Czlonkowska 1998 Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Immunopharmacology 39 167 180 9754903 10.1016/S0162-3109(98)00022-8 1:CAS:528:DyaK1cXkslynt7Y%3D (Pubitemid 28432061)
26. JH Kordower ME Emborg J Bloch SY Ma Y Chu L Leventhal J McBride EY Chen S Palfi BZ Roitberg WD Brown JE Holden R Pyzalski MD Taylor P Carvey Z Ling D Trono P Hantraye N Deglon P Aebischer 2000 Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease Science 290 767 773 11052933 10.1126/science.290.5492.767 1:CAS:528: DC%2BD3cXns1akur4%3D
27. LM Kosloski DM Ha JA Hutter DK Stone MR Pichler AD Reynolds HE Gendelman RL Mosley 2010 Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases J Neurochem 114 1261 1276 20524958 1:CAS:528:DC%2BC3cXhtFSlurnE
28. I Kurkowska-Jastrzebska A Wronska M Kohutnicka A Czlonkowski A Czlonkowska 1999 MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease Acta Neurobiol Exp Wars 59 1 8 10230070 1:STN:280:DyaK1M3ks1Krtw%3D%3D (Pubitemid 29100019)
29. I Kurkowska-Jastrzebska A Wronska M Kohutnicka A Czlonkowski A Czlonkowska 1999 The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse Exp Neurol 156 50 61 10192776 10.1006/exnr.1998.6993 1:CAS:528:DyaK1MXis1equrk%3D (Pubitemid 29152982)
30. JW Langston LS Forno J Tetrud AG Reeves JA Kaplan D Karluk 1999 Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure Ann Neurol 46 598 605 10514096 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F 1:CAS:528:DyaK1MXmvVGitbg%3D (Pubitemid 29466438)
31. C Laurie A Reynolds O Coskun E Bowman HE Gendelman RL Mosley 2007 CD4+ T cells from copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease J Neuroimmunol 183 60 68 17196666 10.1016/j.jneuroim.2006.11.009 1:CAS:528:DC%2BD2sXhs1Citbk%3D (Pubitemid 46204910)
32. L Li J Lu SS Tay SM Moochhala BP He 2007 The function of microglia, either neuroprotection or neurotoxicity, is determined by the equilibrium among factors released from activated microglia in vitro Brain Res 1159 8 17 17572395 10.1016/j.brainres.2007.04.066 1:CAS:528:DC%2BD2sXotVWqurk%3D (Pubitemid 47058024)
33. LF Lin DH Doherty JD Lile S Bektesh F Collins 1993 GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons Science 260 1130 1132 8493557 10.1126/science.8493557 1:CAS:528:DyaK2cXks1Gguw%3D%3D (Pubitemid 23186789)
34. PL McGeer S Itagaki H Akiyama EG McGeer 1988 Rate of cell death in parkinsonism indicates active neuropathological process Ann Neurol 24 574 576 3239957 10.1002/ana.410240415 1:STN:280:DyaL1M7pt1Wqtg%3D%3D
35. P McLaughlin Y Zhou T Ma J Liu W Zhang JS Hong M Kovacs J Zhang 2006 Proteomic analysis of microglial contribution to mouse strain-dependent dopaminergic neurotoxicity Glia 53 567 582 16419087 10.1002/glia.20294
36. K McQuillan MA Lynch KH Mills 2010 Activation of mixed glia by Abeta-specific Th1 and Th17 cells and its regulation by Th2 cells Brain Behav Immun 24 598 607 20060887 10.1016/j.bbi.2010.01.003 1:CAS:528: DC%2BC3cXkvFKls7o%3D
37. A Michelucci T Heurtaux L Grandbarbe E Morga P Heuschling 2009 Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-beta J Neuroimmunol 210 3 12 19269040 10.1016/j.jneuroim.2009.02.003 1:CAS:528:DC%2BD1MXlvF2lt7k%3D
38. AC Murphy SJ Lalor MA Lynch KH Mills 2010 Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis Brain Behav Immun 24 641 651 20138983 10.1016/j.bbi.2010.01.014 1:CAS:528:DC%2BC3cXkvFKls7c%3D
39. I Napoli H Neumann 2009 Microglial clearance function in health and disease Neuroscience 158 1030 1038 18644426 10.1016/j.neuroscience.2008.06.046 1:CAS:528:DC%2BD1MXhsFKrtL8%3D
40. A Nimmerjahn F Kirchhoff F Helmchen 2005 Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo Science 308 1314 1318 15831717 10.1126/science.1110647 1:CAS:528:DC%2BD2MXks1Ciuro%3D (Pubitemid 40746128)
41. RL Nussbaum CE Ellis 2003 Alzheimer's disease and Parkinson's disease N Engl J Med 348 1356 1364 12672864 10.1056/NEJM2003ra020003 1:CAS:528: DC%2BD3sXis1egt7c%3D (Pubitemid 36384104)
42. J Parkinson 2002 An essay on the shaking palsy 1817 J Neuropsychiatry Clin Neurosci 14 223 236 11983801 10.1176/appi.neuropsych.14.2.223 discussion 222
43. AD Reynolds R Banerjee J Liu HE Gendelman RL Mosley 2007 Neuroprotective activities of CD4+ CD25+ regulatory T cells in an animal model of Parkinson's disease J Leukoc Biol 82 1083 1094 17675560 10.1189/jlb.0507296 1:CAS:528:DC%2BD2sXht1KqsbzI (Pubitemid 350133504)
44. AD Reynolds DK Stone RL Mosley HE Gendelman 2009 Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets J Immunol 182 4137 4149 19299711 10.4049/jimmunol.0803982 1:CAS:528:DC%2BD1MXjsVSjtLg%3D
45. AD Reynolds DK Stone RL Mosley HE Gendelman 2009 Proteomic studies of nitrated alpha-synuclein microglia regulation by CD4+ CD25+ T cells J Proteome Res 8 3497 3511 19432400 10.1021/pr9001614 1:CAS:528:DC%2BD1MXms1egu7Y%3D
46. AD Reynolds DK Stone JA Hutter EJ Benner RL Mosley HE Gendelman 2010 Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease J Immunol 184 2261 2271 20118279 10.4049/jimmunol.0901852 1:CAS:528:DC%2BC3cXitV2ksr0%3D
47. V Sanchez-Guajardo F Febbraro D Kirik M Romero-Ramos 2010 Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease PLoS ONE 5 e8784 20098715 10.1371/journal.pone.0008784
48. K Sriram JM Matheson SA Benkovic DB Miller MI Luster JP O'Callaghan 2002 Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease FASEB J 16 1474 1476 12205053 1:CAS:528:DC%2BD38XntFSjsrk%3D
49. DK Stone AD Reynolds RL Mosley HE Gendelman 2009 Innate and adaptive immunity for the pathobiology of Parkinson's disease Antioxid Redox Signal 11 2151 2166 19243239 10.1089/ars.2009.2460 1:CAS:528:DC%2BD1MXpvFaru7w%3D